ID,Compound,Test Type,IC50,EC50,Clinical Trials,Notes
68,Camostat mesylate,In vitro (pseudovirus),~1,≥500,"Phase 2a/4 (NCT04321096, NCT04338906)",10
69,Nafamostat,In vitro,22.50,≥100,NCT04352400,19
70,MI-432,In vitro,≤10,≥50,Preclinical,180
71,MI-1900,In vitro,≤50,≥50,Preclinical,180
72,Amantadine,In vitro,≥100,≥100,Preclinical,187
73,Chlorpromazine,In vitro,≥100,≥100,Preclinical,187
74,E64-d,In vitro,~4.487,≥0,Preclinical,187
75,Chloroquine,In vitro,2.71,273.20,"Several clinical trials (ChiCTR2000029609 et al.)",97
76,Hydroxychloroquine,In vivo (macaques),4.51,249.50,"Several clinical trials (ChiCTR2000029803, ChiCTR2000029868, ChiCTR2000029898, ChiCTR2000029899, ChiCTR2000029992, ChiCTR2000030054, NCT04315948)",124
83,Omeprazole,In vitro,17.06,≥40,Preclinical,146
29,Calpain inhibitors II,In vitro,2.07 ± 0.76,≥100,Preclinical,86
30,Calpain inhibitors XII,In vitro,0.49 ± 0.18,≥100,Preclinical,86
87,Leflunomide,In vitro,41.49,879.0,Preclinical,210
88,Brequinar,In vitro,0.123,231.3,Preclinical,210
89,S312,In vitro,1.56,158.2,Preclinical,210
90,S416,In vitro,0.017,178.6,Preclinical,210
91,ROC-325,In vitro,3.28 ± 0.57,>30,Preclinical,212
92,Clomipramine,In vitro,13.6 ± 2.96,>30,Preclinical,212
93,Hycanthone,In vitro,5.79 ± 0.26,14.2,Preclinical,212
94,Mefloquine,In vitro,3.85 ± 0.24,8.78,Preclinical,212
95,Dithioerythritol thiosulfonate 16,In vitro,50,≥500,Preclinical,214
96,VPS34-IN1,In vitro,0.55,≥50,Preclinical,218
97,PIK-III,In vitro,0.12,≥50,Preclinical,218
98,Orlistat,In vitro,21.25,≥1000,Preclinical,218
99,Triacsin C,In vitro,0.04,≥50,Preclinical,218
100,MI-1851,In vitro,≤10,≥50,Preclinical,180
101,Decanoyl-RVKR-chloromethylketone (dec-RVKR-cmk),In vitro,0.057,318.2,Preclinical,221
102,Homoharringtonine,In vitro,2.55,59.75,Preclinical,99
103,Emetine,In vitro,0.46,56.46,Preclinical,99
104,2-Deoxy-d-glucose (2-DG),In vitro,9090,–,Preclinical,228
105,Pladienolide B,In vitro,0.007,–,Preclinical,228
106,Ribavirin,In vitro,70,–,NCT04356677,228
107,NMS-873,In vitro,0.025,–,Preclinical,140
108,Cycloheximide,In vitro,0.17,–,Preclinical,228
109,Baricitinib,–,–,–,"Phase 2,3,4 (2020-001854-23, 2020-001354-22, NCT04358614)",
110,Nitazoxanide,In vitro,2.12,>35.53,"Phase 2, 3 (NCT04341493, NCT01056380, NCT04348409)",19
111,JIB-04,In vitro,0.695,>300,Preclinical,237
112,Fenofibrate,In vitro,20,>100,Preclinical,187
114,Clemizole hydrochloride,In vitro,23.94,≥40,Preclinical,146
115,Benztropine mesylate,In vitro,17.79,>50,Preclinical,244
116,Fluphenazine dihydrochloride,In vitro,8.98,20.02,Preclinical,244
117,Amodiaquine hydrochloride,In vitro,5.64,>38.63,Preclinical,244
118,Amodiaquine hydrochloride dihydrate,In vitro,4.94,34.42,Preclinical,244
119,Thiethylperazine maleate,In vitro,8.02,18.37,Preclinical,244
120,Triparanol,In vitro,6.41,21.21,Preclinical,244
121,Terconazole,In vitro,16.14,41.46,Preclinical,244
122,Fluspirilene,In vitro,5.32,30.33,Preclinical,244
123,Clomipramine hydrochloride,In vitro,7.59,>29.68,Preclinical,244
124,Promethazine hydrochloride,In vitro,10.44,>42.59,Preclinical,244
125,Toremifene citrate,In vitro,11.3,20.51,Preclinical,244
126,Tamoxifen citrate,In vitro,8.98,37.96,Preclinical,244
127,Imatinib mesylate,In vitro,5.32,>30.86,Preclinical,244
128,Bruceine A,In vitro,0.011,31.4,Preclinical,246
129,Bufalin,In vitro,0.018,>40,Preclinical,246
130,Cinobufagin,In vitro,0.018,>40,Preclinical,246
131,Bufotaline,In vitro,0.0259,>40,Preclinical,246
132,Periplocoside,In vitro,0.0657,>40,Preclinical,246
133,Brusatol,In vitro,0.0492,19,Preclinical,246
134,Digoxin,In vitro,0.1541,>40,Preclinical,246
135,Veratridine,In vitro,2.376,>100,Preclinical,246
136,Oridonin,In vitro,1.462,>40,Preclinical,246
137,Isoalantolactone,In vitro,1.483,>40,Preclinical,246
138,Isoliensinine,In vitro,1.615,40,Preclinical,246
139,Alantolactone,In vitro,1.724,36.7,Preclinical,246
140,Cryptotanshinone,In vitro,5.024,>100,Preclinical,246
141,Dehydrocostus lactone,In vitro,2.322,36.2,Preclinical,246
142,Momordinic,In vitro,3.529,>40,Preclinical,246
143,Liensinine,In vitro,2.537,25.4,Preclinical,246
144,Dehydrodiisoeugenol,In vitro,10.29,≥100,Preclinical,246
145,Cornuside,In vitro,5.262,≥40,Preclinical,246
146,Roburicacid,In vitro,5.267,≥40,Preclinical,246
147,Coniferylaldehyde,In vitro,11.03,≥40,Preclinical,246
148,Panduratin A,In vitro,0.81,14.71,Preclinical,247